CREBBP and neoplasm: However, upon CBP malfunction due to mutations, the BCL6-SMRT-HDAC3 complex overacts in enhancer deacetylation of the B-cell signaling pathway without opponents, leading to B-cell lymphomagenesis.376 In contrast, HDAC4 was a tumor suppressor.